BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17137171)

  • 1. [Mutations of hemochromatosis gene in volunteer blood donors and Chilean porphyria cutanea tarda patients].
    Wolff CF; Armas RM; Frank J; Poblete PG
    Medicina (B Aires); 2006; 66(5):421-6. PubMed ID: 17137171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of porphyria cutanea tarda with hereditary hemochromatosis.
    Mehrany K; Drage LA; Brandhagen DJ; Pittelkow MR
    J Am Acad Dermatol; 2004 Aug; 51(2):205-11. PubMed ID: 15280838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukocyte antigen haplotypes and HFE mutations in Spanish hereditary hemochromatosis and sporadic porphyria cutanea tarda.
    Gonzalez-Hevilla M; de Salamanca RE; Morales P; Martínez-Laso J; Fontanellas A; Castro MJ; Rojo R; Moscoso J; Zamora J; Serrano-Vela JI; Arnaiz-Villena A
    J Gastroenterol Hepatol; 2005 Mar; 20(3):456-62. PubMed ID: 15740492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porphyria cutanea tarda, hepatitis C, uroporphyrinogen decarboxylase and mutations of HFE gene. A case-control study.
    Cribier B; Chiaverini C; Dali-Youcef N; Schmitt M; Grima M; Hirth C; Lacour JP; Chosidow O
    Dermatology; 2009; 218(1):15-21. PubMed ID: 19001803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.
    Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1201-6. PubMed ID: 17062032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
    Skowron F; Bérard F; Grézard P; Wolf F; Morel Y; Perrot H
    Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.
    Sampietro M; Piperno A; Lupica L; Arosio C; Vergani A; Corbetta N; Malosio I; Mattioli M; Fracanzani AL; Cappellini MD; Fiorelli G; Fargion S
    Hepatology; 1998 Jan; 27(1):181-4. PubMed ID: 9425935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C282Y and H63D mutation of the hemochromatosis gene in German porphyria cutanea tarda patients.
    Tannapfel A; Stölzel U; Köstler E; Melz S; Richter M; Keim V; Schuppan D; Wittekind C
    Virchows Arch; 2001 Jul; 439(1):1-5. PubMed ID: 11499833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France.
    Dereure O; Aguilar-Martinez P; Bessis D; Perney P; Vallat C; Guillot B; Blanc F; Guilhou JJ
    Br J Dermatol; 2001 Mar; 144(3):533-9. PubMed ID: 11260010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance and prevalence of the C282Y gene mutation of primary hemochromatosis in the pathogenesis of pophyria cutanea tarda].
    Malina L; Zd'árský E; Dandová S; Michalíková H; Cerná M; Cimburová M
    Cas Lek Cesk; 2000 Nov; 139(23):728-30. PubMed ID: 11191743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porphyria cutanea tarda: the etiological importance of mutations in the HFE gene and viral infection is population-dependent.
    Hift RJ; Corrigall AV; Hancock V; Kannemeyer J; Kirsch RE; Meissner PN
    Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):853-9. PubMed ID: 12699243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemochromatosis (HFE) and transferrin receptor-1 (TFRC1) genes in sporadic porphyria cutanea tarda (sPCT).
    Lamoril J; Andant C; Gouya L; Malonova E; Grandchamp B; Martásek P; Deybac JC; Puy H
    Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):33-41. PubMed ID: 11929045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemochromatosis gene sequence deviations in German patients with porphyria cutanea tarda.
    Frank J; Poblete-Gutiérrez P; Weiskirchen R; Gressner O; Merk HF; Lammert F
    Physiol Res; 2006; 55 Suppl 2():S75-83. PubMed ID: 17298224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphyria cutanea tarda, C282Y, H63D and S65C HFE gene mutations and hepatitis C infection: a study from southern France.
    Chiavérini C; Halimi G; Ouzan D; Halfon P; Ortonne JP; Lacour JP
    Dermatology; 2003; 206(3):212-6. PubMed ID: 12673077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porphyria cutanea tarda associated with Cys282Tyr mutation in HFE gene in hereditary hemochromatosis: a case report and review of the literature.
    Young LC
    Cutis; 2007 Nov; 80(5):415-8. PubMed ID: 18189029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of H63D homozygosity in a Basque population with hemochromatosis.
    Castiella A; Zapata E; de Juan MD; Otazua P; Fernandez J; Zubiaurre L; Arriola JA;
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1295-8. PubMed ID: 20594259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of hemochromatosis-related HFE C282Y/H63D gene mutations in patients on chronic dialysis.
    Canavese C; Bergamo D; Barbieri S; Timbaldi M; Thea A; Martina G; Damiani D; Fenoglio R; Donati-Marella B; Priolo G
    Clin Nephrol; 2002 Dec; 58(6):438-44. PubMed ID: 12508966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda.
    Brady JJ; Jackson HA; Roberts AG; Morgan RR; Whatley SD; Rowlands GL; Darby C; Shudell E; Watson R; Paiker J; Worwood MW; Elder GH
    J Invest Dermatol; 2000 Nov; 115(5):868-74. PubMed ID: 11069625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron overload in porphyria cutanea tarda.
    Sampietro M; Fiorelli G; Fargion S
    Haematologica; 1999 Mar; 84(3):248-53. PubMed ID: 10189391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients.
    Vieira FM; Nakhle MC; Abrantes-Lemos CP; Cançado EL; Reis VM
    An Bras Dermatol; 2013; 88(4):530-40. PubMed ID: 24068123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.